Zydus Pharmaceuticals (USA) Inc recalls
Every recall we track for Zydus Pharmaceuticals (USA) Inc — 96 in all, from 2012–2026 — plus the complaints and injury reports the public filed about them. 4 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Zydus Pharmaceuticals (USA) Inc more than tripled in 2025 (28, up from 9 in 2024). 1% rated “stop using now”.
All FDA recall records for Zydus Pharmaceuticals (USA) Inc since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 4 | 3 | 7 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 1 | 7 | 9 | 17 |
| 2020 | 0 | 0 | 2 | 3 | 5 |
| 2021 | 0 | 0 | 3 | 0 | 3 |
| 2022 | 0 | 0 | 0 | 1 | 1 |
| 2023 | 0 | 0 | 4 | 1 | 5 |
| 2024 | 1 | 1 | 5 | 2 | 9 |
| 2025 | 0 | 2 | 10 | 16 | 28 |
| 2026 (to date) | 0 | 2 | 0 | 3 | 5 |
Zydus Pharmaceuticals (USA) Inc recalls before 2017
Recalls on record by year.
Most common reasons for Zydus Pharmaceuticals (USA) Inc recalls
What to do if you have a recalled Zydus Pharmaceuticals (USA) Inc product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Zydus Pharmaceuticals (USA) Inc recalls
55 shown- Use cautionDrug
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences
Zydus recalls 70,776 vials of Hydrocortisone Sodium Succinate for injection due to failed impurity specifications. Check lot numbers LB00047A and LB00048A.
Zydus PharmaceuticalsOct 1, 2026 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda,
Zydus Pharmaceuticals recalls 25mg Mirabegron Extended-Release Tablets due to N-Nitroso impurity found in some batches. This may pose a risk to health. Affected products have specific lot numbers and expiration dates.
Zydus PharmaceuticalsAug 5, 2026 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,
Zydus Pharmaceuticals recalls 500mg erythromycin tablets with N-Nitroso-Desmethyl-Erythromycin above safe limits. Rx-only medication from India distributed in US. Stop using immediately.
Zydus PharmaceuticalsApr 29, 2026 - Use cautionDrug
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd.,
Zydus Pharmaceuticals recalls specific lots of Icosapent Ethyl Capsules due to failed specifications including red dots and melted capsules.
Zydus PharmaceuticalsMar 9, 2026 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India,
Zydus Pharmaceuticals recalls 1g Icosapent Ethyl capsules (NDC 70710-1592-07) due to oxidation from capsule leakage. Affected lots expire 2/2027 or 4/2027. Stop using if you have these capsules.
Zydus PharmaceuticalsDec 30, 2025 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India,
Zydus Pharmaceuticals recalls 100mg traZODONE tablets with a dent on the surface due to manufacturing defect. This may affect safety but does not cause serious injury. Check NDC 68382-806-10 and lot # EA00237A for affected units.
ZydusDec 19, 2025 - Use cautionDrug
Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd.,
Zydus Pharmaceuticals recalls specific lots of Bromocriptine Mesylate Capsules, USP, 5 mg due to failed impurity specifications. Check your bottle's lot number.
ZydusOct 23, 2025 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count
Zydus Pharmaceuticals recalls 25mg clomipramine capsules due to nitrosamine impurities exceeding FDA limits. These capsules may pose health risks. Consumers should check product details and contact the manufacturer.
Zydus PharmaceuticalsOct 22, 2025 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,
Zydus Pharmaceuticals recalls 0.5mg Entecavir tablets due to failed impurity tests. This medication is prescription-only and may contain unsafe levels of organic impurities.
Zydus PharmaceuticalsSep 24, 2025 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,
Zydus Pharmaceuticals recalls 1 mg Entecavir tablets due to failed impurity specifications. Patients should contact their doctor for guidance on safe use.
Zydus PharmaceuticalsSep 4, 2025 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd.,
Zydus Pharmaceuticals recalls 50mg chlorpromazine tablets due to potential N-Nitroso Desmethyl Chlorpromazine contamination exceeding safety limits. Affected lots from India and US distribution.
Zydus PharmaceuticalsSep 3, 2025 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile,
Zydus Pharmaceuticals recalls specific Succinylcholine Chloride Injection vials due to failed impurities tests. This medication, used for muscle relaxation during surgery, may contain harmful degradation products that could cause serious injury if used improperly.
Zydus PharmaceuticalsAug 27, 2025 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l.,
Zydus Pharmaceuticals recalls Icosapent Ethyl capsules due to burnt or melted capsules from oxidation. Affected lots manufactured in Italy, distributed in the US. Stop using if capsules appear burnt or melted.
Zydus PharmaceuticalsMay 30, 2025 - Use cautionDrug
Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only,
Zydus Pharmaceuticals recalls specific lots of Esomeprazole Magnesium 20 mg single dose packets due to failed impurity specifications.
ZydusMay 13, 2025 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences
Zydus Pharmaceuticals recalls 10mg chlorpromazine tablets due to potential impurity levels exceeding safety limits. Affected lots manufactured in India with specific NDC and expiration date.
Zydus PharmaceuticalsApr 3, 2025 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by:
Zydus Pharmaceuticals recalls 75mg Venlafaxine tablets due to foreign material found in one tablet. This is a prescription-only product with specific lot numbers and expiration dates.
Zydus PharmaceuticalsMar 21, 2025 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1839-1; b) 6 x 50 mL
Zydus Pharmaceuticals recalls Nelarabine injection due to failed impurities and degradation. This medication, used for cancer treatment, may have harmful substances that could cause serious health issues if used.
Zydus PharmaceuticalsFeb 13, 2025 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by:
Zydus Pharmaceuticals recalls 40 mg Esomeprazole packets due to incorrect NDC numbers on the label. Check your lot M408002.
Zydus PharmaceuticalsNov 14, 2024 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd.,
Zydus Pharmaceuticals recalls Micafungin 100mg vials due to cross contamination risk. This affects prescription-only injectable medication manufactured in India and distributed in the US. No specific remedy is listed in the recall notice.
Zydus PharmaceuticalsJul 2, 2024 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial
Zydus Pharmaceuticals recalls Verapamil Hydrochloride Injection due to cross contamination risk. Affected lots have specific NDC numbers and expiration dates. Patients should contact the manufacturer for details.
Zydus PharmaceuticalsJul 2, 2024 - Use cautionDrug
Zydus Pharmaceuticals (USA) Inc recalls Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC,
Zydus Pharmaceuticals recalls cyanocobalamin injection vials with glass particles that could cause injury during medical use. Affected lots manufactured in India expire July 2024.
Zydus PharmaceuticalsJun 27, 2024 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and
Zydus Pharmaceuticals recalls 37.5mg Venlafaxine Extended-Release Capsules due to failed dissolution testing. These capsules may not release medication properly, risking ineffective treatment. Contact Zydus for details.
Zydus PharmaceuticalsJun 21, 2024 - Stop using nowDrug
Zydus Pharmaceuticals (USA) Inc recalls Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited,
Zydus Pharmaceuticals recalls estradiol transdermal system (0.025mg/day) due to failed impurities and degradation. Rx-only product with specific lot numbers and expiration dates. Stop using immediately if affected.
Zydus PharmaceuticalsMay 16, 2024 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare
Zydus Pharmaceuticals recalls 5mg Oxybutynin Chloride Extended-Release Tablets due to failed dissolution tests at 6 months. Affected products have NDC # 68382-255-01 and expire 11/2024.
Zydus PharmaceuticalsOct 19, 2023 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC
Zydus Pharmaceuticals recalls 100 and 500-tablet Oxybutynin Chloride Extended-Release tablets due to failed dissolution specifications. This may affect medication effectiveness.
Zydus PharmaceuticalsSep 21, 2023 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC
Zydus Pharmaceuticals recalls 0.6mg colchicine tablets due to failed impurities testing. Affected lots may contain unsafe levels of beta-lumicolchicine. Consumers should contact the manufacturer for details.
Zydus PharmaceuticalsFeb 24, 2023 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Fulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx Only, Product of India,
Zydus Pharmaceuticals recalls Fulvestrant injection due to failed impurities and degradation specifications. This prescription drug, sold in single-dose prefilled syringes, may pose health risks if used improperly.
Zydus PharmaceuticalsJul 15, 2022 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India,
Zydus Pharmaceuticals recalls 25mg Carvedilol tablets due to foreign paroxetine tablets found in some bottles. Report of two paroxetine tablets in the bottle poses a potential risk.
Zydus PharmaceuticalsAug 13, 2021 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED
Zydus Pharmaceuticals recalls Acyclovir Sodium Injection vials due to crystallization complaints. This may affect IV infusion safety. Check NDC 68382-049-01 for affected products.
Zydus PharmaceuticalsFeb 18, 2021 - Lower riskDrug
Zydus Pharmaceuticals (USA) Inc recalls Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Rx only,
Zydus Pharmaceuticals recalls 15mg Lansoprazole Delayed-Release tablets due to failed dissolution specifications. Rx-only tablets with NDC 68382-771-77 were manufactured in India and distributed in the US. No remedy specified in recall notice.
Zydus PharmaceuticalsDec 3, 2020 - UnratedDrug
Zydus Pharmaceuticals (USA) Inc recalls Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only,
Zydus Pharmaceuticals recalls 15mg Lansoprazole Delayed-Release tablets due to failed dissolution specification. Rx-only product with NDC 68382-771-77, lot M005681, exp 3/2022. No specific remedy stated in recall notice.
Zydus PharmaceuticalsOct 27, 2020 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Ethacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial, Rx Only, Manufactured by: Cadila Healthcare
Zydus Pharmaceuticals recalls 50mg/vial Ethacrynate Sodium injections due to cGMP deviations. Affected lots manufactured in India, distributed in US. Consumers should contact for details.
Zydus PharmaceuticalsJan 31, 2020 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India
Zydus Pharmaceuticals recalls specific lots of 4 mg Methylprednisolone tablets due to CGMP deviations and potential cross-contamination.
Zydus PharmaceuticalsMay 6, 2019 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Acyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed
Zydus Pharmaceuticals USA recalls 400mg Acyclovir tablets due to label mix-up with Carvedilol tablets. Affected bottles may contain incorrect medication. Contact for details.
Zydus PharmaceuticalsApr 25, 2019 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India;
Zydus Pharmaceuticals recalls 3.125mg Carvedilol tablets due to foreign tablets found in some bottles. Customers should check their bottles for light yellow fragments.
Zydus PharmaceuticalsApr 22, 2019 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC
Zydus Pharmaceuticals USA recalls 30mg Paroxetine tablets due to presence of Risperidone tablets in some bottles. This could cause unintended medication intake. Return or contact for remedy.
Zydus PharmaceuticalsNov 20, 2017 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India
Zydus Pharmaceuticals recalls 30mg paroxetine tablets due to risperidone tablets found in bottles. This could cause unintended medication effects. Affected products include specific lot numbers and NDC codes.
Zydus PharmaceuticalsAug 18, 2017 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls Divalproex Sodium Delayed Release Tablets, USP, 250 mg 100-count bottle (NDC 68382-032-01), b.) 500-count bottle (NDC
Zydus Pharmaceuticals USA recalls 250mg and 500-count Divalproex Sodium Delayed Release Tablets due to failed dissolution specifications. This may affect medication effectiveness.
ZydusMay 10, 2017 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC
Zydus Pharmaceuticals recalls 500mg Divalproex Sodium Delayed Release Tablets due to failed dissolution specifications and stability issues. Affected products include specific NDC numbers and expiration dates.
Zydus PharmaceuticalsMar 15, 2017 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC
Zydus Pharmaceuticals USA recalls 50mg atenolol tablets that may contain foreign paroxetine tablets. Consumers should check product labels and contact Zydus for details.
Zydus PharmaceuticalsMar 6, 2017 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b)
Zydus Pharmaceuticals USA recalls 300mg BuPRODION XL tablets with failed dissolution specs. These tablets may not release medication properly. Contact for return instructions.
Zydus PharmaceuticalsNov 2, 2016 - Lower riskDrug
Zydus Pharmaceuticals USA Inc recalls BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila
Zydus Pharmaceuticals USA recalls 500-count BuPropion XL 300mg tablets due to failed dissolution testing. This may affect medication effectiveness. Check NDC 68382-354-05 and lot number MR3365 for affected products.
ZydusAug 3, 2016 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC
Zydus recalls 223,776 bottles of Venlafaxine HCL ER 150mg capsules due to failed dissolution specifications. Check lot numbers and expiration dates for affected units.
Zydus PharmaceuticalsJul 19, 2016 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only, Manufactured by: Cadila Healthcare ltd.,
Zydus Pharmaceuticals recalls specific lots of 5 mg Bromocriptine Mesylate capsules due to failed impurity specifications. Check your lot numbers.
Zydus PharmaceuticalsMay 9, 2016 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd.,
Zydus Pharmaceuticals recalls specific lots of risperidone orally disintegrating tablets due to failed impurity specifications. Check your bottle's lot number.
Zydus PharmaceuticalsJan 14, 2016 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by:
Zydus Pharmaceuticals recalls 19,536 units of Benzonatate Capsules USP 100 mg due to wet or leaking capsules. Check your lot numbers.
Zydus PharmaceuticalsDec 23, 2014 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls Benzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad,
Zydus recalls Benzonatate Capsules due to wet or leaking capsules. Check lot numbers MP2137, MP2138, MP2139, MP3614, MP5611, and MP5613 for affected bottles.
Zydus PharmaceuticalsNov 26, 2014 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Amlodipine Besylate Tablets, USP 10 mg, Rx Only, 90 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd.
Zydus Pharmaceuticals recalls Lot MP4344 of Amlodipine Besylate 10mg tablets due to brown spot discoloration. Check your bottle and consult a pharmacist.
Zydus PharmaceuticalsOct 1, 2014 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad,
Zydus recalls 63,648 bottles of Benzonatate 200 mg capsules because they may contain co-mingled 100 mg capsules. Check your lot numbers immediately.
Zydus PharmaceuticalsSep 24, 2014 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls TOPIRAMATE Tablets 200 mg, 60 Tablet Bottles, Rx Only. Manufactured by Cadila Healthcare Ltd. Ahmedabad, India
Zydus recalls 14,568 bottles of Topiramate 200mg tablets due to the presence of incorrect 100mg tablets. Check your lot number MN9828.
Zydus PharmaceuticalsSep 15, 2014 - Stop using nowDrug
Zydus Pharmaceuticals USA Inc recalls ZyGenerics ATENOLOL Tablets, USP 25 mg 1000 count bottle, Rx Only Manufactured by: Cadila Healthcare Ltd. Ahmedabad,
Zydus recalls ZyGenerics Atenolol 25 mg tablets due to superpotent drug risk. Check your NDC and lot number for details on this Class II recall.
ZyGenericsAug 5, 2014 - Stop using nowDrug
Zydus Pharmaceuticals USA Inc recalls PROMETHAZINE HYDROCHLORIDE Tablets, USP, 25 mg, 100 Tablet Bottles, Rx Only. Manufactured by: Cadila Healthcared Ltd.,
Zydus Pharmaceuticals recalls 10,200 bottles of 25 mg Promethazine tablets due to the presence of foreign atenolol tablets. Check your lot number.
Zydus PharmaceuticalsMay 8, 2014 - Use cautionDrug
Zydus Pharmaceuticals USA Inc recalls Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad,
Zydus Pharmaceuticals recalls Warfarin Sodium Tablets, USP 2 mg due to oversized tablets. Check your lot MM5767 for this Class I recall.
Zydus PharmaceuticalsMay 13, 2013 - UnratedDrug
Zydus Pharmaceuticals USA Inc recalls Venlafaxine Hydrochloride Tablets, 75 mg*, 100-count tablets per bottle, Rx only, Manufactured by: Cadila Healthcare
Zydus recalls 13,320 bottles of 75mg Venlafaxine due to excessive broken/chipped tablets. Check lot MM8490.
Zydus PharmaceuticalsMar 5, 2013 - Stop using nowDrug
Zydus Pharmaceuticals USA Inc recalls Metformin Hydrochloride Tablets, USP, 1000 mg, Rx only, 1000 count tablets per Bottle, Manufactured by: Cadila
Zydus Pharmaceuticals recalls specific lots of Metformin Hydrochloride 1000 mg tablets due to brown specks and metal shavings found in the product.
Zydus PharmaceuticalsMar 14, 2012
Zydus Pharmaceuticals (USA) Inc recall questions
How many recalls has Zydus Pharmaceuticals (USA) Inc had?
96 recalls from Zydus Pharmaceuticals (USA) Inc are on record with U.S. safety agencies, from 2012–2026.
What is the most recent Zydus Pharmaceuticals (USA) Inc recall?
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences, dated Oct 1, 2026. Every Zydus Pharmaceuticals (USA) Inc recall is listed on this page, newest first.
Why are Zydus Pharmaceuticals (USA) Inc products recalled?
The most common reasons on record: Failed Dissolution Specifications (6); Failed Impurities/Degradation Specifications (3); Failed Impurities/Degradation Specifications. (3); Cross contamination with other products (2).
What should I do if I have a recalled Zydus Pharmaceuticals (USA) Inc product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Zydus Pharmaceuticals (USA) Inc recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.